Bausch Health Co. Inc. (BHC) Posts Q4 Adjusted EBITDA of $898 Million, Revs Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Bausch Health Companies Inc. Announces Fourth-Quarter And Full-Year 2019 Results And Provides 2020 Guidance
February 19, 2020 6:59 AM ESTLAVAL, Quebec, Feb. 19, 2020 /PRNewswire/ --Â
Fourth-Quarter 2019 Financial Results Revenues of $2.224 Billion GAAP Cash Generated from Operations of $234 Million GAAP Net Loss of $1.516 Billion Adjusted EBITDA (non-GAAP)1 of $898 Million Full-Year 2019 Financial Results Revenues of $8.601 Billion GAAP Cash Generated from Operations of $1.501 Billion GAAP Net Loss of $1.788 Billion Adjusted EBITDA (non-GAAP)1 of $3.571 Billion Delivered Total Company Reported Revenue Growth of 5% in the Fourth Quarter and 3% for... More